USA Financial Formulas’s Axon Enterprise AXON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,756
Closed -$1.45M 254
2025
Q1
$1.45M Buy
2,756
+1,018
+59% +$596K 0.24% 29
2024
Q4
$1.03M Buy
+1,738
New +$945K 0.16% 63
2024
Q2
Sell
-124
Closed -$38.8K 309
2024
Q1
$38.8K Buy
+124
New +$34.5K 0.01% 249
2023
Q4
Sell
-837
Closed -$167K 361
2023
Q3
$167K Sell
837
-847
-50% -$167K 0.25% 103
2023
Q2
$329K Buy
1,684
+639
+61% +$132K 0.5% 48
2023
Q1
$235K Buy
+1,045
New +$208K 0.38% 42
2019
Q1
Sell
-8,662
Closed -$593K 138
2018
Q4
$593K Buy
8,662
+94
+1% +$4.88K 0.15% 108
2018
Q3
$541K Buy
+8,568
New +$578K 0.14% 115

Other funds holding AXON

USA Financial Formulas's AXON Position: Q2 2025 in Review

USA Financial Formulas sold out of Axon Enterprise (AXON) in Q2 2025, closing a stake of 2,756 shares — an estimated $1.45M sold.

USA Financial Formulas first reported a position in AXON in Q3 2018 and held it in 8 quarters. The position peaked at $1.45M in Q1 2025. 1,178 funds tracked by Wall St. Rank hold AXON as of Q2 2025.

  • USA Financial Formulas reported no remaining Axon Enterprise position as of Q2 2025 after selling out during the quarter.
  • USA Financial Formulas sold 2,756 Axon Enterprise shares in Q2 2025, an estimated $1.45M.
  • USA Financial Formulas first reported a position in Axon Enterprise in Q3 2018 and held it in 8 quarters.
  • USA Financial Formulas's Axon Enterprise position peaked at $1.45M in Q1 2025.
  • 1,178 funds tracked by Wall St. Rank held Axon Enterprise as of Q2 2025.

Based on USA Financial Formulas's 13F filing for Q2 2025, filed 18 Jul 2025.